Dr. Jeffrey Erwin Indes, MD

Dr. Indes practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Indes' NPI, 1083884100, was assigned on March 4, 2008. Dr. Indes graduated from Icahn School Of Medicine At Mount Sinai in 2001. Dr. Indes holds Massachusetts license 1020537.

Dr. Indes' primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Indes' primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Dr. Indes is also affiliated with Beverly Hospital. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Indes to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Indes practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Indes' primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Indes is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Indes' licenses on file in 5 states: Massachusetts, Connecticut, New York, Florida and Pennsylvania.

Dmand AI lists amputation, leg revascularization, peripheral vascular disease and varicose vein treatment among the conditions Dr. Indes treats.

CMS data shows 289 Medicare services from Dr. Indes across 9 procedure codes in 2024, for 243 Medicare patients. Medicare paid $14,339 for them.

CMS counts 243 Medicare patients who saw Dr. Indes in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Indes' median patient age at 76, with 41% women.

In 2024, Dr. Indes wrote 12 Medicare Part D claims. 92% of them were for generic drugs. They cover 1 drug, with $132 in total drug cost. In 2018, CMS named 32 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Indes for performance year 2024, reported as part of a group.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 37 papers to Dr. Indes, published from 2010 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Endovascular Procedures, Vascular Surgical Procedures and Blood Vessel Prosthesis Implantation. Dr. Indes has published most often in J Vasc Surg. Dr. Indes' most frequent co-authors are Evan C. Lipsitz, MD, Issam Koleilat, MD and Matthew Carnevale, MD.

CMS Open Payments shows 404 general payments to Dr. Indes from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Endologix, Inc. paid the most, $4,306.

Dr. Indes graduated from Icahn School Of Medicine At Mount Sinai in 2001.

Dr. Indes is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.